Computational Drug Discovery and Design

(backadmin) #1
dynamics receptor structures in virtual screen-
ing. J Chem Inf Model 51:1439–1446


  1. Nichols SE, Riccardo B, McCammon JA
    (2012) On the use of molecular dynamics
    receptor conformations for virtual screening.
    Methods Mol Biol 819:93–103

  2. Okimoto N, Futatsugi N, Fuji H, Suenaga A,
    Morimoto G, Yanai R, Ohno Y, Narumi T,
    Taiji M (2009) High-performance drug dis-
    covery: computational screening by combining
    docking and molecular dynamics simulations.
    PLoS Comput Biol 5:e1000528

  3. Rodriguez-Bussey IG, Doshi U, Hamelberg D
    (2016) Enhanced molecular dynamics sam-
    pling of drug target conformations. Biopoly-
    mers 105:35–42

  4. Sliwoski G, Kothiwale S, Meiler J, Lowe EW Jr
    (2014) Computational methods in drug dis-
    covery. Pharmacol Rev 66:334–395

  5. Bartesaghi A, Merk A, Banerjee S, Matthies D,
    Wu X, Milne JLS, Subramaniam S (2015) 2.2 A ̊
    resolution cryo-EM structure of
    β-galactosidase in complex with a cell-
    permeant inhibitor. Science 348:1147–1151

  6. Hughes JP, Rees S, Kalindjian SB, Philpott KL
    (2011) Principles of early drug discovery. Br J
    Pharmacol 162:1239–1249

  7. Kuenemann MA, Sperandio O, Labbe CM,
    Lagorce D, Miteva MA, Villoutreix BO
    (2015) In silico design of low molecular weight
    protein-protein interaction inhibitors: overall
    concept and recent advances. Prog Biophys
    Mol Biol 119:20–32

  8. Ramirez D (2016) Computational methods
    applied to rational drug design. Open Med
    Chem J 10:7–20

  9. Rognan D (2015) Rational design of protein-
    protein interaction inhibitors. Med Chem
    Commun 6:51–60

  10. B-Rao C, Subramanian J, Sharma SD (2009)
    Managing protein flexibility in docking and its
    applications. Drug Discov Today 14:394–400

  11. Cavasotto CN, Abagyan RA (2004) Protein
    flexibility in ligand docking and virtual screen-
    ing to protein kinases. J Mol Biol 337:209–225

  12. Durrant JD, McCammon JA (2010)
    Computer-aided drug-discovery techniques
    that account for receptor flexibility. Curr Opin
    Pharmacol 10:770–774

  13. Totrov M, Abagyan R (2008) Flexible ligand
    docking to multiple receptor conformations: a
    practical alternative. Curr Opin Struct Biol
    18:178–184

  14. Feher M (2006) Consensus scoring for pro-
    tein–ligand interactions. Drug Discov Today
    11:421–428
    27. Politi R, Convertino M, Popov K, Dokholyan
    NV, Tropsha A (2016) Docking and scoring
    with target-specific pose classifier succeeds in
    native-like pose identification but not binding
    affinity prediction in the CSAR 2014 bench-
    mark exercise. J Chem Inf Model
    56:1032–1041
    28. Quiroga R, Villarreal MA (2016) Vinardo: a
    scoring function based on autodock vina
    improves scoring, docking, and virtual screen-
    ing. PLoS One 11:e0155183
    29. Wang Z, Sun H, Yao X, Li D, Xu L, Li Y,
    Tian S, Hou T (2016) Comprehensive evalua-
    tion of ten docking programs on a diverse set of
    protein–ligand complexes: the prediction accu-
    racy of sampling power and scoring power.
    Phys Chem Chem Phys 18:12964–12975
    30. Seifert MHJ (2009) Targeted scoring func-
    tions for virtual screening. Drug Discov
    Today 14:562–569
    31. Leach AR (2001) Molecular modelling: princi-
    ples and applications, 2nd edn. Pearson,
    Dorchester
    32. Ryckaert J-P, Ciccotti G, Berendsen HJC
    (1977) Numerical integration of the cartesian
    equations of motion of a system with con-
    straints: molecular dynamics of n-alkanes. J
    Comput Phys 23:327–341
    33. Schlick T (2002) Molecular modeling and sim-
    ulation: an interdisciplinary guide. Springer,
    New York
    34. Stanley N, De Fabritiis G (2015) High
    throughput molecular dynamics for drug dis-
    covery. Silico Pharmacol 3:3–6
    35. Lin JH, Perryman AL, Schames JR, McCam-
    mon JA (2003) The relaxed complex method:
    accommodating receptor flexibility for drug
    design with an improved scoring scheme. Bio-
    polymers 68:47–62
    36. Sinko W, Lindert S, McCammon JA (2013)
    Accounting for receptor flexibility and
    enhanced sampling methods in computer-
    aided drug design. Chem Biol Drug Des
    81:41–49
    37. Cala O, Remy M-H, Guillet V, Merdes A,
    Mourey L, Milon A, Czaplicki G (2013) Vir-
    tual and biophysical screening targeting the
    gamma-tubulin complex – a new target for
    the inhibition of microtubule nucleation.
    PLoS One 8:e63908
    38. Alonso H, Bliznyuk AA, Gready JE (2006)
    Combining docking and molecular dynamic
    simulations in drug design. Med Res Rev
    26:531–568
    39. Mori T, Miyashita N, Im W, Feig M, Sugita Y
    (2016) Molecular dynamics simulations of
    biological membranes and membrane proteins


176 Gre ́gory Menchon et al.

Free download pdf